4//SEC Filing
GENEREX BIOTECHNOLOGY CORP 4
Accession 0001363585-13-000012
CIK 0001059784operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:26 PM ET
Size
5.6 KB
Accession
0001363585-13-000012
Insider Transaction Report
Form 4
Brusegard David
Chief Operating Officer
Transactions
- Award
Common Stock Purchase Option (Right to Buy)
2013-06-06+595,239→ 595,239 totalExercise: $0.00From: 2013-06-06Exp: 2018-06-06→ Common Stock (595,239 underlying)
Footnotes (1)
- [F1]On June 4, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 595,239 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective June 6, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan.
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001059784
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:26 PM ET
- Size
- 5.6 KB